Your Commercialization Partner for Advanced Therapy Products and Services
In this dynamic and evolving market, differentiation and market adoption are key to revenue growth and sustainability.
Propel
Commercialization Strategy and Implementation
Propel BioSciences is a boutique consultancy specializing in global commercialization strategy and execution, with a particular focus on the cell and gene therapy market as well as the broader biotech sector. With deep industry expertise, Propel BioSciences helps companies navigate the complexities of market entry, sales, marketing, and business development strategies matched to high impact activities. The firm’s tailored approach ensures optimal market positioning, effective sales strategies, and sustainable growth for its clients in the rapidly evolving field of cell and gene therapy. Emphasis is on converting new technology, drug and service provider enthusiasts into near term revenue customers and long term evangelists for your company.
Innovative Commercial Solutions
Fractional C-Suite Leadership
Offering high-impact C-suite expertise—CCO, CBO, or CEO—on a fractional basis to drive strategy development, planning, and execution. We specialize in commercial launches and accelerating revenue growth, providing businesses with executive leadership without the full-time commitment. With our hands-on approach, your business will scale faster and more efficiently
Business Development
- Partnership & Collaboration: Identify and engage in high-value partnerships to fuel growth.
- Strategic Partnering for Exit: Forge strategic alliances to position your business for a successful exit.
- Growth-Focused Strategic Planning: Create sustainable growth strategies that drive long-term success.
- Sales Optimization & Expansion: Optimize sales processes and expand market reach to accelerate revenue growth.
Sales
- Boost Salesforce Performance: Analyze and enhance Salesforce effectiveness to drive better results.
- Accelerate Client Acquisition: Implement targeted strategies for acquiring new clients and converting leads.
- Tailored Value Messaging: Craft sales messaging customized to your audience and buyer personas.
- Optimize Salesforce Management: Streamline Salesforce processes for improved sales team efficiency.
- Strategic Sales Planning: Build short- and long-term strategies for sustainable sales growth.
Strategy Driven Marketing
- Gain a Competitive Edge: In-depth competitive analysis to stay ahead of the market.
- Targeted Digital Marketing: Develop and execute digital marketing strategies that drive engagement and conversions.
- Market Segmentation & Personas: Identify key market segments and craft detailed buyer personas.
- Voice of the Customer (VOC): Leverage VOC insights to align products with customer needs.
- Effective Product Positioning: Create impactful product positioning and branding strategies.
- Market-Based Pricing: Develop pricing models that reflect market demand and maximize profitability.
Sales Training
- Proprietary Selling System: Implement a proven strategic selling system for complex scientific sales.
- Sales Team Evaluation: Analyze and assess sales team capabilities to enhance market penetration.
- Standardized Sales Processes: Develop SOPs to streamline and optimize sales procedures.
- Founder & Startup Training: Tailored sales training for founders and early-stage companies to establish market presence.
- Growth-Driven Sales Training: Equip Series-funded companies with strategies to accelerate market adoption.
- Advanced Sales Training: Empower seasoned professionals to transform good sales into exceptional performance.
Our Team
Our Founder
Susan Nichols is the visionary CEO of Propel BioSciences, leading the company with a deep passion for patient advocacy and a steadfast commitment to diversity in the life sciences. A trailblazer in the cell and gene therapy space since 2010, Susan has held leadership roles throughout the ecosystem, spanning Drug Development, CDMO operations, Engineering Services, and Manufacturing Equipment.
Before joining Propel, Susan served as President and CEO of Falcon Therapeutics, an early-stage genetically modified cell therapy company, where she successfully navigated the complexities of the emerging therapeutic landscape. She also held the role of Chief Business Officer (CBO) at a leading viral vector CDMO, further strengthening her expertise in the manufacturing and commercialization of advanced therapies.
With over two decades of corporate leadership and management experience, including executive roles at Fortune 500 companies like Invetech/Danaher, Thermo Fisher/ASI, Hitachi Chemical, and Roche Diagnostics, Susan has been instrumental in increasing market share, achieving aggressive corporate goals, securing venture capital, and forging strategic alliances, including royalty deals and licensing opportunities.
An active leader in the regenerative medicine community, Susan sits on the Board of Directors for the Alliance for Regenerative Medicine, where she continues to support global access to and adoption of cell and gene therapies.
Our Marketing Director
Angie Higdon is an accomplished Director of Marketing and Research, known for her ability to simplify complexity and foster a culture of learning within her teams. With a focus on market analysis and brand development, she transforms challenges into growth opportunities by aligning marketing strategies with consumer insights and industry trends. Angie’s leadership is rooted in her commitment to professional development, where she empowers her teams to innovate and collaborate effectively.
Her expertise spans market research, brand development, and cross-functional collaboration. Angie excels at turning strategic plans into actionable results, driving continuous improvement in an ever-evolving business landscape. She is dedicated to creating adaptable processes that ensure sustainable growth and success across diverse industries.